Active Pharmaceutical Ingredients
Metformin HCl SR Granules are a ready-to-formulate pharmaceutical intermediate designed to produce sustained-release (SR) oral solid dosage forms of Metformin Hydrochloride. These granules are engineered to release the active ingredient gradually over an extended period, ensuring stable plasma drug levels and improved patient compliance.
| Component | Function |
|---|---|
| Metformin Hydrochloride (HCl) | Active Pharmaceutical Ingredient (API) |
| Hydrophilic Matrix Former (e.g., HPMC, EC) | Sustained Release Polymer – Controls drug release rate and extends duration of action |
| Colloidal Silicon Dioxide | Glidant – Enhances flow properties and prevents clumping or bridging in hoppers/feeders |
| Magnesium Stearate | Lubricant – Prevents sticking to punches/dies and ensures smooth tablet ejection |
| Purified Water | Granulating Solvent – Used in wet granulation; evaporates during drying |
Outsourcing SR Granules through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromise on quality or compliance.
Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Metformin HCl SR Granules or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Metformin HCl SR (Sustained Release) Granules are ready-to-use, pre-formulated granules designed for the manufacture of sustained-release oral dosage forms. They allow for controlled release of Metformin over an extended period (typically 8–12 hours).
Yes. Dissolution can be customized by modifying polymer type, viscosity, granule size, and process parameters.
Yes, Metformin HCl SR Granules are exported globally, meeting the regulatory standards of various markets. Full technical and regulatory documentation is provided, including COA, MSDS, stability data, and DMF (if required).